Top image

Our Research

Here you'll find information about our Flagship programs and other projects. Use the filters below to display research of interest using one of the three categories.
  • T2,T3 | Flagship 2 Pilot and Seed
    Development and implementation barriers of a new patient-reported outcome measure for radiotherapy related inconvenience
    With more than 14 million new cases of cancer being diagnosed globally each year, radiation therapy (RT) has the potential to improve the rates of cure of 3.5 million people by eradicating tum...
    Radiation oncology
  • T2,T3 | Flagship 2 Pilot and Seed
    Pilot evaluation of the implementation of systematic melanoma risk assessment and tailored skin surveillance and patient education in dermatology clinics
    Currently, melanoma screening and surveillance strategies are undertaken opportunistically and mostly rely on a one-size fits all approach or are based around single risk factors such as age, ...
    Skin cancer
  • T1,T2 | Flagship 2 Pilot and Seed
    Dual targeting of stromal and immunological aberrations in pancreatic cancer by combining perlecan inhibition with immunotherapy
    Pancreatic cancer is the 4th leading cause of cancer deaths and has a dismal 5-year survival of <9%, with no meaningful changes in the last four decades. One of the reasons the prognosis is ...
    ImmunotherapyPancreatic cancer
  • T1,T2 | Flagship 2 Pilot and Seed
    Improving survival in melanoma by matching optimal drug therapy for individual patients
    Checkpoint inhibitor immunotherapy has revolutionized the management of advanced melanoma and significantly improved survival. However, half of these patients still die of melanoma.  Ther...
    ImmunotherapySkin cancer
  • WHAT IS EnRICH? The EnRICH program is a prospective clinical cohort of 1000 patients with lung cancer, which aims to better define, treat and care for patients in Sydney Catalyst member hosp...
  • T2,T3 | Flagship 2 Pilot and Seed
    Very low-energy diet before surgery in obese patients undergoing partial liver excision: A pilot randomised control trial (Very Supple Trial)
    Obesity in Australia is an increasingly concerning issue in healthcare. Obesity has been shown to make abdominal surgery more technically challenging and is associated with poorer outcomes. St...
    Surgery
  • T2,T3 | Flagship 2 Pilot and Seed
    Ensuring the symptoms of vulnerable populations are known: Identifying patient barriers and facilitators to completing PROMs in cancer care
    In Australis there are over 300 separately identified languages spoken in homes, with over 20% of Australians speaking a language other than English. In some health care services, this equals a...
    PsychosocialImplementation research
  • T2,T3 | Flagship 2 Pilot and Seed
    Aerobic exercise training during chemotherapy infusion
    Cancer and its treatment often cause physical and psychological side effects. Exercise is well known to benefit people with cancer, especially during treatment. It can reduce side effects such ...
    Evidence into practiceKnowledge translationTreatmentExercise
  • T1,T2 | Flagship 2 Pilot and Seed
    Unraveling the metabolic link between the host and breast cancer disease progression
    Obese and diabetic patients have a far higher risk that lean, healthy people of getting breast cancer, and have worse outcomes when they do get cancer. These examples highlight the crucial and ...
    Breast CancerMetastasis
  • T1,T2 | Flagship 2 Pilot and Seed
    Intravital imaging to overcome pancreatic cancer resistance to immunotherapy
    Survival rates in pancreatic cancer have been at a low standstill (5-year survival of ~9%) for the last decades. There is therefore an urgent need to assess new treatment strategies to effecti...
    ImagingImmunotherapyPancreatic cancer